DOPAMINE-INDUCED INHIBITION OF PROLACTIN AND GROWTH HORMONE SECRETION IN ACROMEGALY
- 1 February 1976
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 307 (7957) , 485
- https://doi.org/10.1016/s0140-6736(76)91508-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- AcromegalyPublished by American Medical Association (AMA) ,1975
- SECRETORY COMPONENT AND SUDDEN-INFANT-DEATH SYNDROMEThe Lancet, 1975
- Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-?-ErgocryptineJournal of Clinical Endocrinology & Metabolism, 1975
- Inhibition by Apomorphine of Prolactin Secretion in Patients with Elevated Serum ProlactinJournal of Clinical Endocrinology & Metabolism, 1974
- Serum Growth Hormone and Prolactin Response to Thyrotropin-Releasing Hormone in Patients with Acromegaly Before and After SurgeryJournal of Clinical Endocrinology & Metabolism, 1974
- DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION1Journal of Clinical Endocrinology & Metabolism, 1974
- Inhibitory Effect of Dopaminergic Stimulation on GH Release in AcromegalyJournal of Clinical Endocrinology & Metabolism, 1974
- Assessment of Somatotrophic Hypophyseal Function in Acromegalic Patients by Estimation of Serum Growth Hormone before and after Surgical TreatmentHormone Research, 1973
- THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)Journal of Clinical Endocrinology & Metabolism, 1972
- Levodopa Suppression of Prolactin in Nonpuerperal GalactorrheaNew England Journal of Medicine, 1971